Here are relevant reports on : nicotine-delivery-market
-
Behavioral Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership), Functionality (Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial), End User (Hospitals, Clinics) - Global Forecasts to 2026
The global behavioral health software market growth is primed to transition from $2.0 billion in 2021 to $4.9 billion by 2026, showcasing a strong CAGR of 19.6%. Factors such as the increasing adoption of behavioral health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, medical professionals are putting a greater emphasis on providing patients with mental illness with high-quality care, favourable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage are driving the growth of this market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) & Region - Global Forecast to 2026
The global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Clinical Decision Support Systems Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) & Region - Global Forecast to 2028
The global clinical decision support systems market growth is primed to transition from $1.7 billion in 2023 to $2.5 billion by 2028, showcasing a strong CAGR of 7.5%. Several factors, such as the implementation of government initiatives supporting the adoption of HCIT solutions, rising government healthcare expenditure, and the presence of skilled IT experts in emerging markets, are expected to support the market growth for CDSS.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
The global microfluidics market growth is primed to transition from USD 22.43 Billion in 2024 to USD 32.67 Billion by 2029, showcasing a strong CAGR of 7.8%. The rising requirement of point-of-care diagnostics is an important factor, that helps to detect cancer, infectious diseases, and chronic illnesses, for which microfluidic devices are preferred due to their accuracy.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Care Management Solutions Market by Component (Software and Services), Delivery Mode (On-Premise and Cloud-Based), Application (Disease Management, Case Management, Utilization Management), End User (Payers, Providers) & Region - Global Forecast to 2026
The global care management solutions market growth is primed to transition from $12.6 billion in 2021 to $21.6 billion by 2026, showcasing a strong CAGR of 11.4%. Key factors driving this growth include initiatives that shift risk from healthcare payers to providers, government regulations promoting patient-centric care, and increasing healthcare IT adoption.
- Published: July 2021
- Price: $ 4950
- TOC Available:
-
Correspondence Management System Market by Component, Delivery Channel (Email, Web, and SMS/MMS), Application (Mailroom Automation, Engineering Document Control), Deployment Model, Organization Size, Industry Vertical, and Region - Global Forecast to 2023
The correspondence management system market size expected to grow from USD 1.9 billion in 2018 to USD 3.5 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 12.6% during the forecast period. The demand for correspondence management system expected to rise over the next 5 years owing to various factors, including the need for reducing planning and budgeting cycles. Moreover, automation of internal and external communication has been immensely growing with the rise of big data and analytics solutions. Major global vendors of Correspondence Management System Market are IBM (US), Microsoft (US), Adobe (US), OpenText (Canada), Pitney Bowes (US), Rosslyn Analytics (England), MicroPact (US), Fabasoft (Austria), NewGen (India), Everteam (France), Xerox (US), Palaxo (UAE), Top Down Systems (US), IT-Blocks (Egypt), and CATEC (UAE).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Healthcare Claims Management Market by Component (Software, and Services), Delivery Mode (On-Premise, and Cloud Based), Type (Integrated, and Standalone), End User (Healthcare Payers, Providers) - Global Forecast to 2023
The global healthcare claims management market is projected to reach USD 13.93 billion by 2023 from USD 10.77 billion in 2018, at a CAGR of 5.3% during the forecast period. The key factors driving the growth of this market are increasing patient volumes, expanding health insurance market, growing importance of denials management, and declining reimbursement rates. Cerner Corporation (US), McKesson Corporation (US), athenahealth (US), eClinicalWorks (US), Optum, Inc, (US), Conifer Health Solutions (US), and nThrive (US) are the key players in the healthcare claims management solutions market. Other players involved in this market are DST Systems (US), Cognizant Technology Solutions (US), Allscripts Healthcare Solutions, Inc. (US), Context 4 Healthcare (US), Health Solutions Plus (US), GE Healthcare (US), RAM Technologies (US), Quest Diagnostics (US), The SSI Group (US), PLEXIS Healthcare Systems (US), and GeBBS Healthcare Solutions (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
